Core Viewpoint - The announcement indicates a strategic collaboration between China Oral Industry and BioHui Biotechnology to enhance their business operations in the medical biotechnology sector, marking a new phase for the company [1] Group 1: Strategic Collaboration - China Digital Health Group, a wholly-owned subsidiary of China Oral Industry, has signed a memorandum of understanding with BioHui Biotechnology to establish a joint venture [1] - The collaboration aims to form qualified medical and biotechnology teams to promote clinical treatment services in the Greater Bay Area hospitals [1] Group 2: Company Growth and Diversification - The board believes that this memorandum signifies a new stage for the company’s entry into the medical biotechnology field and presents opportunities for diversified business development [1] - Through the strategic partnership with BioHui, the company aims to leverage its connections in the Greater Bay Area to broaden its revenue base and enhance overall competitiveness [1]